These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

151 related items for PubMed ID: 8345343

  • 1. Failure of insulin treatment in obese patients with non-insulin-dependent diabetes mellitus.
    Fassberg J, Toffler WL, Fields SA, Loriaux LD.
    J Fam Pract; 1993 Jul; 37(1):76-81. PubMed ID: 8345343
    [Abstract] [Full Text] [Related]

  • 2. Weight loss reverses secondary failure of oral hypoglycaemic agents in obese non-insulin-dependent diabetic patients independently of the duration of the disease.
    Pontiroli AE, Calderara A, Pacchioni M, Cassisa C, Pozza G.
    Diabete Metab; 1993 Jul; 19(1):30-5. PubMed ID: 8504882
    [Abstract] [Full Text] [Related]

  • 3. Long-term benefits of insulin therapy and glycemic control in overweight and obese adults with type 2 diabetes.
    Caballero AE.
    J Diabetes Complications; 2009 Jul; 23(2):143-52. PubMed ID: 18413192
    [Abstract] [Full Text] [Related]

  • 4. Insulin treatment and the problem of weight gain in type 2 diabetes.
    Carver C.
    Diabetes Educ; 2006 Jul; 32(6):910-7. PubMed ID: 17102158
    [Abstract] [Full Text] [Related]

  • 5. Promising new approaches.
    Reasner CA.
    Diabetes Obes Metab; 1999 May; 1 Suppl 1():S41-8. PubMed ID: 11220287
    [Abstract] [Full Text] [Related]

  • 6. Off-label use of exenatide for the management of insulin-resistant type 1 diabetes mellitus in an obese patient with human immunodeficiency virus infection.
    Sheffield CA, Kane MP, Busch RS.
    Pharmacotherapy; 2007 Oct; 27(10):1449-55. PubMed ID: 17896900
    [Abstract] [Full Text] [Related]

  • 7. Weight gain during insulin therapy in patients with type 2 diabetes mellitus.
    Heller S.
    Diabetes Res Clin Pract; 2004 Sep; 65 Suppl 1():S23-7. PubMed ID: 15315867
    [Abstract] [Full Text] [Related]

  • 8. Effects of insulin on body composition in patients with insulin-dependent and non-insulin-dependent diabetes.
    Sinha A, Formica C, Tsalamandris C, Panagiotopoulos S, Hendrich E, DeLuise M, Seeman E, Jerums G.
    Diabet Med; 1996 Jan; 13(1):40-6. PubMed ID: 8741811
    [Abstract] [Full Text] [Related]

  • 9. The management of non-insulin-dependent diabetes mellitus in the elderly.
    Ruoff G.
    J Fam Pract; 1993 Mar; 36(3):329-35. PubMed ID: 8454981
    [Abstract] [Full Text] [Related]

  • 10. Beneficial effects of a long-term oral L-arginine treatment added to a hypocaloric diet and exercise training program in obese, insulin-resistant type 2 diabetic patients.
    Lucotti P, Setola E, Monti LD, Galluccio E, Costa S, Sandoli EP, Fermo I, Rabaiotti G, Gatti R, Piatti P.
    Am J Physiol Endocrinol Metab; 2006 Nov; 291(5):E906-12. PubMed ID: 16772327
    [Abstract] [Full Text] [Related]

  • 11. Management of obesity in NIDDM (non-insulin-dependent diabetes mellitus).
    Cheah JS.
    Singapore Med J; 1998 Aug; 39(8):380-4. PubMed ID: 9844503
    [Abstract] [Full Text] [Related]

  • 12. Glimepiride pharmacokinetics in obese versus non-obese diabetic patients.
    Shukla UA, Chi EM, Lehr KH.
    Ann Pharmacother; 2004 Jan; 38(1):30-5. PubMed ID: 14742789
    [Abstract] [Full Text] [Related]

  • 13. Non-insulin-dependent diabetes mellitus: a clinical strategy.
    Skyler JS.
    Diabetes Care; 1984 Jan; 7 Suppl 1():118-29. PubMed ID: 6376024
    [Abstract] [Full Text] [Related]

  • 14. Treatment of metabolic syndrome.
    Wagh A, Stone NJ.
    Expert Rev Cardiovasc Ther; 2004 Mar; 2(2):213-28. PubMed ID: 15151470
    [Abstract] [Full Text] [Related]

  • 15. Treating non-insulin-dependent diabetes. Oral agents or insulin?
    Shlossberg AH.
    Can Fam Physician; 1993 Jan; 39():119-20, 123-6. PubMed ID: 8435549
    [Abstract] [Full Text] [Related]

  • 16. Effect of insulin and energy restriction on the thermic effect of protein in type 2 diabetes mellitus.
    Gougeon R.
    Obes Res; 2001 Apr; 9(4):241-50. PubMed ID: 11331427
    [Abstract] [Full Text] [Related]

  • 17. Clinical experience with U-500 regular insulin in obese, markedly insulin-resistant type 2 diabetic patients.
    Ballani P, Tran MT, Navar MD, Davidson MB.
    Diabetes Care; 2006 Nov; 29(11):2504-5. PubMed ID: 17065692
    [No Abstract] [Full Text] [Related]

  • 18. [Role of physical activity in the therapy and prevention of Type II diabetes mellitus].
    Lehmann R, Spinas GA.
    Ther Umsch; 1996 Dec; 53(12):925-33. PubMed ID: 9036570
    [Abstract] [Full Text] [Related]

  • 19. Secondary diabetes associated with principal endocrinopathies: the impact of new treatment modalities.
    Resmini E, Minuto F, Colao A, Ferone D.
    Acta Diabetol; 2009 Jun; 46(2):85-95. PubMed ID: 19322513
    [Abstract] [Full Text] [Related]

  • 20. Effect of a 2-day very low-energy diet on skeletal muscle insulin sensitivity in obese type 2 diabetic patients on insulin therapy.
    Jazet IM, Ouwens DM, Schaart G, Pijl H, Keizer H, Maassen JA, Meinders AE.
    Metabolism; 2005 Dec; 54(12):1669-78. PubMed ID: 16311102
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.